Profile data is unavailable for this security.
About the company
Viromed Medical AG is a Germany-based company engaged in the supply of medicines. The Company supplies pharma products to clinics, rehabilitation hospitals, nursing homes, medical practitioners, and others. It conducts research on viruses and bacteria along with developing solutions for medical technology such as cold plasma technology used for wound healing, plasma therapy, and produces medical equipment such as ViroCAP, PulmoPlas, used for curative activities such as in the areas of infection protection, dermatology, and intensive care medicine. Its other products and services include nasal sprays, air purifiers, VitaQuiz, corona tests and others.
- Revenue in EUR (TTM)0.00
- Net income in EUR-80.36k
- Incorporated2021
- Employees--
- LocationViromed Medical AGFlensburger Strasse 18PINNEBERG 25421GermanyDEU
- Phone+49 4 101809960
- Websitehttps://www.viromed-medical-ag.de/
More ▼
Mergers & acquisitions
| Acquired company | VMEDX:GER since announced | Transaction value |
|---|---|---|
| Activcell Group AG | 6.67% | -- |
Data delayed at least 15 minutes, as of Nov 15 2024 16:36 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uni-Bio Science Group Ltd | 62.04m | 12.06m | 48.89m | 458.00 | 4.09 | 1.28 | 3.37 | 0.788 | 0.0159 | 0.0159 | 0.0812 | 0.0507 | 1.27 | 2.23 | 12.21 | 1,249,140.00 | 24.76 | 1.46 | 32.97 | 1.97 | 83.51 | 80.59 | 19.44 | 1.23 | 2.17 | 168.55 | 0.2267 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
| Wakamoto Pharmaceutical Co Ltd | 48.20m | 1.15m | 49.97m | 274.00 | 43.11 | 0.6856 | 13.52 | 1.04 | 5.47 | 5.47 | 228.52 | 344.22 | 0.5106 | 2.00 | 3.29 | 28,945,390.00 | 1.22 | -2.28 | 1.39 | -2.64 | 47.52 | 51.00 | 2.40 | -3.97 | 3.48 | -- | 0.0083 | -- | -10.65 | -6.35 | -21.19 | -- | 4.93 | -- |
| Viromed Medical AG | 0.00 | -80.36k | 50.40m | -- | -- | 1.92 | -- | -- | -0.004 | -0.004 | 0.00 | 0.9789 | 0.00 | -- | -- | -- | -0.399 | -- | -0.399 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 31.26 | -- | -- | -- |
| Aadi Bioscience Inc | 23.81m | -58.58m | 50.79m | 53.00 | -- | 0.7756 | -- | 2.13 | -2.29 | -2.29 | 0.9285 | 2.80 | 0.2225 | 0.696 | 4.09 | 281,685.40 | -54.75 | -50.25 | -65.27 | -56.15 | 87.39 | -- | -246.06 | -473.97 | 4.54 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
| AB Science SA | 1.08m | -6.04m | 51.53m | 45.00 | -- | -- | -- | 47.62 | -0.1204 | -0.1204 | 0.0213 | -0.4697 | 0.0385 | 0.6465 | 6.98 | 20,415.09 | -21.51 | -65.95 | -70.06 | -515.17 | 76.25 | 88.41 | -558.50 | -1,148.98 | 0.798 | -9.11 | -- | -- | 1.25 | -10.63 | 11.97 | -- | -6.55 | -- |
| Tianda Pharmaceuticals Ltd | 46.94m | -5.77m | 51.69m | 695.00 | -- | 0.7778 | -- | 1.10 | -0.022 | -0.022 | 0.1789 | 0.2533 | 0.4341 | 2.97 | 4.46 | 445,745.10 | -5.34 | -- | -7.97 | -- | 45.83 | -- | -12.30 | -- | 0.6748 | -9.51 | 0.1536 | -- | -- | -- | -- | -- | -- | -- |
| K Pharma Inc | 0.00 | -4.14m | 51.98m | 15.00 | -- | 3.19 | -- | -- | -58.58 | -58.58 | 0.00 | 230.79 | 0.00 | 0.00 | -- | 0.00 | -27.16 | -- | -29.66 | -- | -- | -- | -- | -- | 34.85 | -- | 0.00 | -- | -- | -- | 166.34 | -- | -- | -- |
Data as of Nov 15 2024. Currency figures normalised to Viromed Medical AG's reporting currency: Euro EUR
